NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Innovision IPO Subscription Falls to 30 Percent

Innovision, a provider of manpower and toll plaza management services, has seen its initial public offer (IPO) subscription rate decline to 30 percent as of Friday. This comes after the company extended the closing date of its IPO to March 17 and reduced the price band following a lukewarm response from investors.

The price band reduction is likely a result of the company's attempt to boost investor interest in the IPO. However, the move appears to have had a limited impact, with the subscription rate still falling short of expectations. As a result, Innovision will now have an additional week to secure investments before the IPO closes on March 17.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Investor Takeaway

Investors should be cautious of IPOs with lukewarm responses.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.